Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain health applications in Australia and internationally.
Excellent balance sheet and overvalued.
Share Price & News
How has Cogstate's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: COGZ.F's share price has been volatile over the past 3 months.
7 Day Return
US Healthcare Services
1 Year Return
US Healthcare Services
Return vs Industry: Insufficient data to determine how COGZ.F performed against the US Healthcare Services industry.
Return vs Market: Insufficient data to determine how COGZ.F performed against the US Market.
Price Volatility Vs. Market
How volatile is Cogstate's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Cogstate undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate COGZ.F's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate COGZ.F's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: COGZ.F is unprofitable, so we can't compare its PE Ratio to the US Healthcare Services industry average.
PE vs Market: COGZ.F is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate COGZ.F's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: COGZ.F is good value based on its PB Ratio (5.1x) compared to the US Healthcare Services industry average (5.6x).
How is Cogstate forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Cogstate has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Examine Cogstate's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
- While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on theOTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Cogstate's filings and announcementshere.
- Explore growth companies in the Healthcare industry.
How has Cogstate performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: COGZ.F is currently unprofitable.
Growing Profit Margin: COGZ.F is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: COGZ.F is unprofitable, and losses have increased over the past 5 years at a rate of 6.6% per year.
Accelerating Growth: Unable to compare COGZ.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: COGZ.F is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-4.8%).
Return on Equity
High ROE: COGZ.F has a negative Return on Equity (-16.94%), as it is currently unprofitable.
How is Cogstate's financial position?
Financial Position Analysis
Short Term Liabilities: COGZ.F's short term assets ($14.8M) exceed its short term liabilities ($11.9M).
Long Term Liabilities: COGZ.F's short term assets ($14.8M) exceed its long term liabilities ($2.9M).
Debt to Equity History and Analysis
Debt Level: COGZ.F's debt to equity ratio (5.6%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if COGZ.F's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: COGZ.F has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: COGZ.F has sufficient cash runway for 1.1 years if free cash flow continues to grow at historical rates of 6.7% each year.
What is Cogstate current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate COGZ.F's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate COGZ.F's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if COGZ.F's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if COGZ.F's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of COGZ.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Bradley O'Connor, also known as Brad, B.Bus, CA, has been the Chief Executive Officer and Managing Director of Cogstate Limited since December 1, 2005 and served as its Chief Financial Officer since Ma ...
CEO Compensation Analysis
Compensation vs Market: Brad's total compensation ($USD655.04K) is about average for companies of similar size in the US market ($USD589.02K).
Compensation vs Earnings: Brad's compensation has been consistent with company performance over the past year.
|CEO, MD & Executive Director||14.67yrs||US$655.04k||3.45% |
|Chief Scientific Officer||no data||US$416.58k||0.29% |
|Financial Controller & Company Secretary||0.58yr||no data||no data|
|Interim Chief Technology Officer||0.58yr||no data||no data|
|General Counsel & Company Secretary||no data||no data||no data|
|Senior Director of Strategic Initiatives & Communication||0.17yr||no data||no data|
|Senior Vice President of Clinical Science||2.5yrs||no data||no data|
|Chief Commercial Officer||0.75yr||no data||no data|
|Principal Consultant||no data||no data||no data|
Experienced Management: COGZ.F's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.
|CEO, MD & Executive Director||14.67yrs||US$655.04k||3.45% |
|Independent Non-Executive Director||10yrs||US$64.79k||2.53% |
|Non-Executive Chairman||no data||US$101.51k||13.88% |
|Independent Non-Executive Director||1yr||no data||0.079% |
|Non-Executive Director||6.75yrs||US$65.15k||15.12% |
|Independent Non-Executive Director||3.58yrs||US$52.98k||0.032% |
Experienced Board: COGZ.F's board of directors are considered experienced (6.8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.8%.
Cogstate Limited's company bio, employee growth, exchange listings and data sources
- Name: Cogstate Limited
- Ticker: COGZ.F
- Exchange: OTCPK
- Founded: 1999
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: AU$110.594m
- Listing Market Cap: AU$79.256m
- Shares outstanding: 170.15m
- Website: https://www.cogstate.com
Number of Employees
- Cogstate Limited
- 255 Bourke Street
- Level 2
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|CGS||ASX (Australian Securities Exchange)||Yes||Ordinary Shares||AU||AUD||Feb 2004|
|COGZ.F||OTCPK (Pink Sheets LLC)||Yes||Ordinary Shares||US||USD||Feb 2004|
|CGS||CHIA (Chi-X Australia)||Yes||Ordinary Shares||AU||AUD||Feb 2004|
Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain health applications in Australia and internationally. The ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/08/14 12:17|
|End of Day Share Price||2020/08/13 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.